Scalpel Versus Diathermy in Transverse Abdominal Skin Incision During Cesarean Section
Launched by CAIRO UNIVERSITY · Apr 2, 2024
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
Surgical scalpels are traditionally used for skin incisions during a Caesarean delivery; the great evolutions in electrosurgical devices bring an alternative method for skin incision by the usage of cutting diathermy.
The current comparative study was conducted in Kasr Al-Ainy hospital obstetric theaters between January 2022 and June 2022. Consents were obtained from all participants. 120 participants were included in this study, divided into 2 groups 60 in each group;Diathermy group and scalpel group respectively .
• Randomization achieved using computer generated randomization sequences...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Elective cesarean section.
- • Women with body mass index less than 30.
- • Transverse skin incision.
- Exclusion Criteria:
- • Women with medical disorder that can affect wound healing as diabetes, hypertension, chronic anemia and with chronic skin conditions as psoriasis and eczema.
- • Women with Autoimmune disorders.
- • Cardiac patients on pacemakers and patients on anticoagulants.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Cairo, Egypt
Patients applied
Trial Officials
Shaimaa El Shemy, MD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported